Magenta Lifecare FY26 Results: Growth and Major Order

Total Income reached Rs 15.23 crore, while Profit After Tax touched Rs 11.35 lakh.
Reader Takeaway: Strong revenue growth and a landmark Reliance order are positive, though rising debt requires investor monitoring.

What just happened

Magenta Lifecare has filed its annual report for FY 2025-26, reporting a 41.4% surge in total income to Rs 15.23 crore. The company improved its EBITDA margin by 217 basis points, reaching 7.50%. The bottom line also expanded, with net profit rising to Rs 11.35 lakh from Rs 8.28 lakh in the previous year.

Why this matters

The company’s operational scale is increasing, validated by its largest institutional order to date: 6,000 mattresses supplied to Reliance Industries for their Dahej facility. This move underscores the company's transition from a smaller player to a supplier for large-scale industrial projects.

Business and Operational Update

Magenta Lifecare has expanded its footprint to 13 states and UTs, supported by a network of 220 dealers and 11 distributors. The launch of the 'Magenta GOLD' premium mattress range has further diversified their product mix. Additionally, the company is committing capital to manufacturing, with Rs 1.83 crore currently locked in Capital Work-in-Progress (CWIP) at their Vadodara facility.

Risks to watch

Investors should note the 164.4% year-on-year increase in total borrowings, which now stand at Rs 5.29 crore. While operational cash flow remains positive at Rs 113.06 lakh, the aggressive expansion and capital investment strategy have increased the company's debt burden significantly. Managing these leverage ratios while scaling up will be critical for future stability.

Corporate Governance

During the fiscal year, the company finalized the appointment of M/s. VCA & Associates as Statutory Auditors and appointed Mr. Aditya Gautambhai Chhunchha as Company Secretary. The Board also moved to regularize the appointment of Mr. Nikhil Bharatbhai Mistry as an Independent Director.